CRISPR/Cas9 targeting of the androgen receptor suppresses the growth of LNCaP human prostate cancer cells.
about
CRISPR/Cas9 targeting of the androgen receptor suppresses the growth of LNCaP human prostate cancer cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
CRISPR/Cas9 targeting of the a ...... P human prostate cancer cells.
@en
CRISPR/Cas9 targeting of the a ...... P human prostate cancer cells.
@nl
type
label
CRISPR/Cas9 targeting of the a ...... P human prostate cancer cells.
@en
CRISPR/Cas9 targeting of the a ...... P human prostate cancer cells.
@nl
prefLabel
CRISPR/Cas9 targeting of the a ...... P human prostate cancer cells.
@en
CRISPR/Cas9 targeting of the a ...... P human prostate cancer cells.
@nl
P2093
P2860
P356
P1476
CRISPR/Cas9 targeting of the a ...... P human prostate cancer cells.
@en
P2093
Chaogang Wei
Fengjiao Wang
Junkang Shen
Wenlu Zhao
P2860
P304
P356
10.3892/MMR.2017.8257
P577
2017-12-12T00:00:00Z